|
TVGN Tevogen Bio Holdings Inc 1860871 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-5,761,940.00 |
| Balance Sheet |
|
Current Assets
|
$2,009,260.00 |
|
Assets
|
$4,727,741.00 |
|
Current Liabilities
|
$6,150,584.00 |
|
Liabilities
|
$13,616,501.00 |
|
Equity
|
$-8,888,760.00 |
|
Shares Out
|
4255107.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,739,172.00 |
|
Investing Cash Flow
|
$-64,439.00 |
| Market Analysis |
Market Cap
|
$27,105,031.59 |
|
Price
|
$6.37 |
|
PB
|
8.50 |
|
EPS
|
-1.52 |
|
FCF
|
$-5,803,611.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:55 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:46 |
|
| Apr |
May |
Jun |
| 2026-03-31 |
-8.08 |
|
|
2026-05-15 |
-1.61 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
-0.03 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TVGN documents filed with the SEC.
TVGN Filings
Clear
